NCT00042666 2020-08-10A Study of Oral LY317615 in Relapsed or Refractory Diffuse Large B-Cell Lymphomas.Eli Lilly and CompanyPhase 2 Completed55 enrolled 13 charts
NCT00332202 2018-09-10PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily EnzastaurinEli Lilly and CompanyPhase 3 Completed758 enrolled 20 charts